All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @regrowwithazmain on TikTok · 44s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @regrowwithazmain's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00It has been 178 days since Turkey and this is like the first time I'm probably scared about my hair girl
  2. 0:06I've been on do task drive for about a month and I'm really just hoping it's a shedding phase
  3. 0:11But that does not look good at all
  4. 0:13Come on. Um, I've been on finasteride for pretty much a year before my before my thing and then after
  5. 0:20Since so I really hope this shed is just a shed and not just like a result because I'm my son Rufal
  6. 0:27So I'm getting real natural lighting on this end
  7. 0:30I'm really not happy with what I see. Hopefully the next 100 days makes a comeback in the density that's going on over here
  8. 0:37Who's what is that? What is that? I didn't have that before so hopefully is just a shed. What is out?

@regrowwithazmain's hair thinning claim, fact-checked

Azmain’s Hair Journey🧙‍♂️

TikTok creator

11.5K viewsWatch on TikTok

Quick answer

The creator is approximately 6 months post hair transplant and roughly 1 month into dutasteride use after approximately 1 year on finasteride, now observing visible thinning they attribute to a possible dutasteride-induced shed. Post-transplant shedding timelines and DHT-suppression-induced anagen recruitment can overlap and be difficult to distinguish clinically without serial photography and scalp evaluation. A physician should assess whether this represents normal transitional shedding, shock loss continuation, or a treatment response issue before any medication adjustments are made.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @regrowwithazmain's hair thinning claim, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@regrowwithazmain's hair thinning claim, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@regrowwithazmain's hair thinning claim, fact-checked" from Azmain's Hair Journey🧙‍♂️. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is approximately 6 months post hair transplant and roughly 1 month into dutasteride use after approximately 1 year on finasteride, now observing visible thinning they attribute to a possible dutasteride-induced shed.

The reason this review is not generic is the source wording and the canonical claim label "trt i m thinning again hair hairgrowthjourney balding hairlo." In this clip, the useful excerpt is: "It has been 178 days since Turkey and this is like the first time I'm probably scared about my hair girl I've been on do task drive for about a month and I'm really just hoping it's a shedding phase But that does not look good at all Come..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A shed appearing at 4-8 weeks on dutasteride is expected, not automatically a sign of failure, because simultaneous anagen recruitment causes old hairs to exit before new ones are visible (Garza et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is approximately 6 months post hair transplant and roughly 1 month into dutasteride use after approximately 1 year on finasteride, now observing visible thinning they attribute to a possible dutasteride-induced shed.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is approximately 6 months post hair transplant and roughly 1 month into dutasteride use after approximately 1 year on finasteride, now observing visible thinning they attribute to a possible dutasteride-induced shed. Post-transplant shedding timelines and DHT-suppression-induced anagen recruitment can overlap and be difficult to distinguish clinically without serial photography and scalp evaluation. A physician should assess whether this represents normal transitional shedding, shock loss continuation, or a treatment response issue before any medication adjustments are made.
  • Dutasteride suppresses approximately 90-95% of DHT conversion versus finasteride's roughly 70%, a difference large enough to trigger a new shedding cycle even in patients already on finasteride (Olsen et al., 2006, JAAD).
  • A shed appearing at 4-8 weeks on dutasteride is expected, not automatically a sign of failure, because simultaneous anagen recruitment causes old hairs to exit before new ones are visible (Garza et al., 2012, Journal of Clinical Investigation).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Dutasteride suppresses approximately 90-95% of DHT conversion versus finasteride's roughly 70%, a difference large enough to trigger a new shedding cycle even in patients already on finasteride (Olsen et al., 2006, JAAD).
  • A shed appearing at 4-8 weeks on dutasteride is expected, not automatically a sign of failure, because simultaneous anagen recruitment causes old hairs to exit before new ones are visible (Garza et al., 2012, Journal of Clinical Investigation).
  • At 178 days post hair transplant, grafts are still maturing. Transplant-related shock loss can persist through month 6-8, making it difficult to separate procedure effects from drug effects without serial clinical photos.
  • Dutasteride is not FDA-approved for male androgenetic alopecia in the United States. It is used off-label. Patients should confirm use with a licensed prescriber, not adjust dosing based on social media timelines.
  • Shedding that continues past month 3-4 on dutasteride, or density that does not improve by month 6, warrants clinical re-evaluation rather than continued waiting.
  • Transitioning from finasteride to dutasteride, or stacking both, can amplify the shed response compared to starting dutasteride de novo, because the follicular environment is already partially DHT-suppressed before the deeper block hits.
  • The creator's instinct to wait and observe is reasonable short-term, but a dermatologist or hair transplant specialist review with comparative photos is the appropriate next step at the 3-month dutasteride mark.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @regrowwithazmain actually say?

The creator is 178 days post hair transplant in Turkey, has been on finasteride for roughly a year, recently added dutasteride about a month ago, and is now seeing visible thinning that is alarming them. Their core hope is that this is a temporary shed, not drug-related loss or transplant failure. They say "I really hope this shed is just a shed and not just like a result."

They also identify as someone with a family history of hair loss, referencing being "my son Rufal" which appears to be a reference to the Norwood scale or a colloquial term for their pattern. The video is essentially a real-time anxiety check, not a medical claim dump, which actually makes it more honest than most hair content on TikTok. They are not selling anything. They are scared.

Does the science back this up?

Yes, a dutasteride-triggered shed is a real and documented phenomenon. The creator's fear is medically grounded, even if they do not fully articulate why it happens.

Dutasteride inhibits both Type I and Type II 5-alpha reductase, blocking roughly 90-95% of DHT conversion compared to finasteride's roughly 70% of Type II alone. When DHT is suppressed that aggressively, follicles that were in a prolonged telogen or transitional phase can be simultaneously recruited into anagen, creating a mass shed of old hairs before new growth appears. This is sometimes called a "dread shed." A randomized controlled trial by Olsen et al. (2006, Journal of the American Academy of Dermatology) confirmed dutasteride's superior DHT suppression over finasteride and noted early shedding as a recognized transitional effect. The shed typically peaks around weeks 6-12 and resolves by month 4-6 in responders.

What did they get wrong (or right)?

They got the core biology right without knowing it. A one-month shed on dutasteride is textbook timing. They deserve credit for that.

What they are missing is a bit more nuance. Finasteride and dutasteride are not interchangeable in terms of onset and shed patterns. Switching or stacking them can create a more pronounced shed than starting either drug from scratch, because the follicular environment is already partially suppressed and then gets hit with a much deeper DHT block. Research by Gubelin Harcha et al. (2014, Journal of the American Academy of Dermatology) comparing the two drugs found dutasteride produced significantly better hair count outcomes at 24 weeks, but the early adjustment period can look alarming.

The post-transplant timing also matters. At 178 days, transplanted grafts are still maturing. Shock loss from the procedure itself can persist or resurface through month 6-8. Attributing everything to dutasteride at this stage may be premature. They should not panic yet, but they should also not assume it is definitely just a shed.

What should you actually know?

If you are on finasteride and switching to or adding dutasteride, expect a possible shed. That is not a sign the drug is failing. It may actually be a sign it is working.

The mechanism is the same one that makes minoxidil shed happen: accelerated follicle cycling. Garza et al. (2012, Journal of Clinical Investigation) showed that forcing follicles into anagen simultaneously causes a visible shed phase before density improves. For a post-transplant patient, the compounding effect of graft maturation timelines and drug-induced cycling changes makes interpretation especially tricky without a dermatologist or hair transplant specialist reviewing photos over time.

If shedding continues past month 3-4 on dutasteride, or if density does not recover by month 6, that warrants clinical evaluation, not just more waiting. Dutasteride is not approved by the FDA for androgenetic alopecia in men in the United States, though it is approved in South Korea and Japan and is widely used off-label. That regulatory gap means patients often rely on TikTok creators like this one for information, which is exactly why accuracy matters.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Azmain’s Hair Journey🧙‍♂️ · TikTok creator

11.5K views on this video

I’m thinning again #hair #hairgrowthjourney #balding #hairloss #hairmaxxing

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about dutasteride suppresses approximately 90-95% of dht conversion versus finasteride's roughly?

Dutasteride suppresses approximately 90-95% of DHT conversion versus finasteride's roughly 70%, a difference large enough to trigger a new shedding cycle even in patients already on finasteride (Olsen et al., 2006, JAAD).

What does the video say about a shed appearing at 4-8 weeks on dutasteride?

A shed appearing at 4-8 weeks on dutasteride is expected, not automatically a sign of failure, because simultaneous anagen recruitment causes old hairs to exit before new ones are visible (Garza et al., 2012, Journal of Clinical Investigation).

What does the video say about at 178 days post hair transplant, grafts?

At 178 days post hair transplant, grafts are still maturing. Transplant-related shock loss can persist through month 6-8, making it difficult to separate procedure effects from drug effects without serial clinical photos.

What does the video say about dutasteride?

Dutasteride is not FDA-approved for male androgenetic alopecia in the United States. It is used off-label. Patients should confirm use with a licensed prescriber, not adjust dosing based on social media timelines.

What does the video say about shedding?

Shedding that continues past month 3-4 on dutasteride, or density that does not improve by month 6, warrants clinical re-evaluation rather than continued waiting.

What does the video say about transitioning from finasteride to dutasteride,?

Transitioning from finasteride to dutasteride, or stacking both, can amplify the shed response compared to starting dutasteride de novo, because the follicular environment is already partially DHT-suppressed before the deeper block hits.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Azmain’s Hair Journey🧙‍♂️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.